
POEM Group
Apr 6, 2025, 06:35
Margherita Ambrosini: Epidemiology, biology and evolving management of MSI-H/dMMR cancers
Margherita Ambrosini, Medical Doctor, Oncology Clinical and Research Fellow at the Fondazione IRCCS National Cancer Institute in Milan, Italy:
“In this review we go through the key aspects that characterize MSI-H/dMMR cancers, in light of recent diagnostic advances and the successes of immune checkpoint inhibitors in both advanced and early stage disease.
Have a look!”
“Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers.”
Authors: Margherita Ambrosini, Paolo Manca, Vincenzo Nasca, Carolina Sciortino, Filippo Ghelardi, Jenny F. Seligmann, Julien Taieb, Filippo Pietrantonio
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 6, 2025, 06:32
Apr 6, 2025, 06:18
Apr 6, 2025, 06:01
Apr 6, 2025, 05:46